MFSD2A and metastatic malignant neoplasm in the lymph nodes: As listed in Table 2, the low expression of MFSD2A was significantly correlated with poor histological differentiation (P = 0.012), but not with age, sex, tumor size, live cirrhosis, lymph node metastasis, recurrence, serum AFP level, or HBsAg status.